Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Ephrin B2 ELISA Kit (AC3220)
Cat.#: ASET-1809
Specifications
Description Human Ephrin B2 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Ephrin B2 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 5.29 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 80-1280 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2234 Human Cx30 ELISA Kit (AC3645) Quantitative inquiry ASET-2096 Human DDR2 ELISA Kit (AC3507) Quantitative inquiry ASET-1115 Human AVPR1B ELISA Kit (AC2526) Quantitative inquiry ASET-1856 Mouse P Cadherin ELISA Kit (AC3267) Quantitative inquiry ASET-2189 Human NeuroD2 ELISA Kit (AC3600) Quantitative inquiry ASET-2107 Rat Slit2 ELISA Kit (AC3518) Quantitative inquiry ASET-2458 Human Meteorin ELISA Kit (AC3869) Quantitative inquiry ASET-1783 Mouse DDR2 ELISA Kit (AC3194) Quantitative inquiry ASET-1611 Mouse Rln3 ELISA Kit (AC3022) Quantitative inquiry ASET-1184 Rat Somatostatin ELISA Kit (AC2595) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket